Partridge Andrew John 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Partridge Andrew John
EVP & Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+9,733→ 9,733 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (9,733 underlying) - Award
Common Stock
2021-02-08+2,136→ 23,636 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.